v3.25.2
Cover Page - USD ($)
 12 Months Ended
May 31, 2025
Jul. 16, 2025
Nov. 30, 2024
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Current Fiscal Year End Date --05-31    
Document Period End Date May 31, 2025    
Document Transition Report false    
Entity File Number 0-50761    
Entity Registrant Name AngioDynamics, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 11-3146460    
Entity Address, Address Line One 14 Plaza Drive    
Entity Address, City or Town Latham    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 12110    
City Area Code 518    
Local Phone Number 795-1400    
Title of 12(b) Security Common Stock, par value $.01 per share    
Trading Symbol ANGO    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 245,095,250
Entity Common Stock, Shares Outstanding   40,633,885  
Documents Incorporated by Reference
DOCUMENTS INCORPORATED BY REFERENCE
The information required for Part III of this Annual Report on Form 10-K is incorporated by reference to the registrant’s Proxy Statement for its 2025 Annual Meeting of Stockholders to be filed within 120 days of the registrant's fiscal year ended May 31, 2025. 		   
Entity Central Index Key 0001275187    
Amendment Flag false    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY